Meeting Banner
Abstract #3427

Evaluating the Metabolic Profile of Prostate Cancer Cells Using an MR Compatible Bio-Reactor

Mithun Kailavasan1, Steven Reynolds1, Adriana Bucur1, Samira Kazan2, Tooba Alizadeh2, Gillian M. Tozer2, Ishtiaq Rehman3, Martyn Paley1

1Academic Radiology, University of Sheffield, Sheffield, Yorkshire, United Kingdom; 2Oncology, University of Sheffield, Sheffield, Yorkshire, United Kingdom; 3Human Metabolism, University of Sheffield, Sheffield, Yorkshire, United Kingdom

Prostate cancer cells with varying metastatic potential (LNCaP and LNCaP-LN3) were cultured in a customized cell bioreactor system, adapted for a 9.4T Nuclear Magnetic Resonance (NMR) probe, which allowed extended cell survival. Several metabolite levels were continuously measured over time, including lactate, fatty acid, alanine, choline, glutamine and creatine, both with and without the addition of a pyruvate dehydrogenase kinase inhibitor, dichloroacetate (DCA). Zymography was used to assess LDH isoenzymes. Rat p22 sarcoma cells were used as a control. Zymography assays (n=4), showed an absence of the LDH-B subunit in both LNCaP-LN3 and rat p22 cell lines. LNCaP-LN3 and rat p22 cells had a 18600mol/108 cells (p<0.001) and 6600mol/108 cells (p=0.039) median difference, respectively, in lactate levels compared to LNCaP. Median Cho/Cr ratios at 1hr decreased following DCA treatment in LNCaP and LNCAP-LN3 (p<0.001). Creatine levels increased over time in all 3 cell lines by showing efficiency of the bioreactor design.

Abstract PDF Presentation Video

Keywords

absence academic acid acids acquisition adapted addition additional alanine alters although amongst antigen anxiety applications assays broadband cancer cause causing cell cells chemical choline clinical clinically coaxial combination common compatible compounds concentration confirmed control cultured customized database deaths decreased despite detection diagnosis double drastically evaluate evaluating expected expressed false fatty gradient great greater highest highly human identification identify important inhibitor kingdom lactate largest latter located lowest measured median metabolic metabolism metabolites metastatic monitored need negative oncology optimized organic particularly patients plot poorly positive potential previously probe produce production profile progression pronounced prostate published radiology rapidly reactor reduced reduction related representative respectively sarcoma series serum spectra spectral spectroscopy subunit subunits suggests suppression system targeting therapy third treated treatment tube urgent utilized validated water whereas whisker widely